MARKET

MYCOF

MYCOF

Mydecine Innovations Group Inc
OTCPK
0.011
NaN%
Closed 09:30 04/19 EDT
OPEN
--
PREV CLOSE
0.011
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
110.00
52 WEEK LOW
0.0073
MARKET CAP
616.15K
P/E (TTM)
-0.0245
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at MYCOF last week (0408-0412)?
Weekly Report · 6d ago
Weekly Report: what happened at MYCOF last week (0401-0405)?
Weekly Report · 04/08 09:59
Weekly Report: what happened at MYCOF last week (0325-0329)?
Weekly Report · 04/01 09:58
Weekly Report: what happened at MYCOF last week (0318-0322)?
Weekly Report · 03/25 09:59
Weekly Report: what happened at MYCOF last week (0311-0315)?
Weekly Report · 03/18 09:58
Weekly Report: what happened at MYCOF last week (0304-0308)?
Weekly Report · 03/11 09:57
Weekly Report: what happened at MYCOF last week (0226-0301)?
Weekly Report · 03/04 09:58
Oregon House passes bill to end hard drug decriminalization
New Zealand this week reversed a ban on tobacco sales to younger generations. Thailand just announced that it would ban the use of recreational cannabis by the end of this year. Oregon is getting second thoughts on decriminalizing hard drugs. The first U.S. State to decriminalize hard drugs has declared a fentanyl state of emergency.
Seeking Alpha · 03/01 11:42
More
About MYCOF
Mydecine Innovations Group Inc. is a Canada-based biopharma and life sciences company. The Company is focused on the research, development and acceptance of alternative nature-sourced medicine. Its portfolio of companies includes Mydecine Health Sciences (MHS), Mindleap Health Inc. (Mindleap) and NeuroPharm, Inc (NPI). MHS is focused on developing fungtional mushroom products and psychedelic medicines for the consumer and professional healthcare market. NPI is a veterans-focused healthcare company that is developing pharmaceutical and natural health products for mental wellness in vulnerable populations, including veterans, emergency medical services (EMS) personnel and other high-risk constituencies. NPI is developing psilocybin-assisted psychotherapy to treat chronic post-traumatic stress disorder (PTSD). Mindleap offers a digital health platform that enables people connect with mental health specialists, who can help them to develop habits for a healthy mind.

Webull offers Mydecine Innovations Group Inc stock information, including OTCPK: MYCOF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYCOF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MYCOF stock methods without spending real money on the virtual paper trading platform.